Blood tests for prediction of deep endometriosis: A case-control study

Table 1 Baseline clinical characteristics and serum lipid profiles of participants

Variable	Control group (n = 95)	DE (n = 31)	P value
Age (yr), mean ± SD	31.57 ± 5.03	32.10 ± 5.13	0.61
BMI (kg/m2), mean ± SD	21.37 ± 2.67	20.36 ± 2.17	0.06
Parity, n (%)			0.41
0	35 (71.43)	14 (28.57)
≥ 1	60 (77.92)	17 (22.08)
Abortion, n (%)			0.90
0	50 (75.76)	16 (24.24)
1	18 (72.00)	7 (28.00)
≥ 2	27 (77.14)	8 (22.86)
TG (mmol/L), median (Q1-Q3)	0.80 (0.64-1.12)	0.81 (0.57-0.99)	0.33
TC (mmol/L), median (Q1-Q3)	4.27 (3.80-4.82)	4.09 (3.80-4.77)	0.80
HDL (mmol/L), median (Q1-Q3)	1.32 (1.14-1.59)	1.39 (1.19-1.55)	0.70
LDL (mmol/L), median (Q1-Q3)	2.16 (1.83-2.60)	2.16 (1.81-2.69)	0.98

Data are mean ± SD for normally distributed variables, medians (Q1-Q3) for variables without a normal distribution, and n (%) for categories variables. BMI: Body mass index, DE: Deep endometriosis; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; TC: Total cholesterol; TG: Total triglycerides.